Merck’s stock price slipped 0.74% to $94.02, lagging behind the broader market’s gains. This dip came despite Merck ...

B, consensus $2.58B. Sees comparable store sales increase 1%-2%. Sees capex $83M-$88M. The company is accelerating ...

Reports Q4 sales $667.1M, consensus $674.52M. Comparable store sales increased 2.8% from the prior year increase of 3.9%.”We were very pleased ...

“Due to significant reductions in demand for these products, the company has decided to cease operations at the plant,” the ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

The most recent trading session ended with Merck (MRK) standing at $93.43, reflecting a -1.37% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily ...

The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...

Market traders are also anticipating at least two more rate cuts by the end of 2025 to support the Canadian economy in the face of slower global growth and trade uncertainties. In the U.S., stocks ...

Merck has launched a $1 billion vaccine manufacturing facility in Durham, North Carolina, as part of a $12 billion U.S.

The Trump administration argues that investments and growth from top businesses means more for the economy than the recent stock market rout.

The department store company that dates back to 1670 announced the move Friday evening, saying it has been facing “significant” pressures, including subdued consumer spending, trade tensions ...

Merck (MRK) ended the recent trading session at $94, demonstrating a +0.87% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 1.78%. Meanwhile, ...